megestrol acetate suspension
strides pharma science limited - megestrol acetate (unii: tj2m0fr8es) (megestrol - unii:ea6ld1m70m) - megestrol acetate oral suspension, usp is indicated for the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (aids). history of hypersensitivity to megestrol acetate or any component of the formulation. known or suspected pregnancy.
butalbital, acetaminophen and caffeine- butalbital, acetaminophen, and caffeine tablet
strides pharma science limited - butalbital (unii: khs0az4jvk) (butalbital - unii:khs0az4jvk), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - butalbital, acetaminophen and caffeine tablets are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. caution in this regard is required because butalbital is habit-forming and potentially abusable. this product is contraindicated under the following conditions: – hypersensitivity or intolerance to any component of this product – patients with porphyria. barbiturates may be habit-forming: tolerance, psychological dependence, and physical dependence may occur especially following prolonged use of high doses of barbiturates. the average daily dose for the barbiturate addict is usually about 1500 mg. as tolerance to barbiturates develops, the amount needed to maintain the same level of intoxication increases; tolerance to a fatal dosage, however, does not increase more than two-fold. as this occurs, the margin between an intoxication d
eptifibatide strides 0.75 mg/ml solution for infusion
strides arcolab international limited - eptifibatide - solution for infusion - 0.75 mg/ml
eptifibatide strides 2 mg/ml solution for injection
strides arcolab international limited - eptifibatide - solution for injection - 2 mg/ml
methotrexate strides 25 mg/ml solution for inj/inf
strides arcolab international limited - methotrexate - solution for inj/inf - 25 mg/ml
cytarabine strides 20mg/ml, solution for injection/infusion (5ml)
strides arcolab international limited - cytarabine 20 mg/ml - solution for infusion or injection
cytarabine strides 20mg/ml, solution for injection/infusion (25ml)
strides arcolab international limited - cytarabine 20 mg/ml - solution for infusion or injection
cytarabine strides 20mg/ml, solution for injection/infusion (50ml)
strides arcolab international limited - cytarabine 20 mg/ml - solution for infusion or injection
cytarabine strides 100mg/ml, solution for injection/infusion (20ml)
strides arcolab international limited - cytarabine 100 mg/ml - solution for infusion or injection
oxaliplatin strides 5mg/ml concentrate for solution for infusion
strides arcolab international limited - oxaliplatin 5 mg/ml - concentrate for solution for infusion